July 19 (Reuters) - Canadian health regulator said on Friday it will keep importing U.S.-based Kaleo Inc's epinephrine auto-injectors and expects adequate supply of the devices in the country over the coming months.
Health Canada's announcement comes after Pfizer Inc (NYSE:PFE) PFE.N , that makes Mylan NV's MYL.O EpiPens sold globally, notified that a shortage of the 0.3 mg dose of the emergency allergy shots may lead to temporary supply constraints in Canada.